Trial intelligence / Profile preview

Intranasal ketamine versus oral midazolam with nitrous oxide for pediatric eye examination under anesthesia

IRCT20160307026950N51Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, triple-blind trial comparing Intranasal ketamine + nitrous oxide with Oral midazolam + nitrous oxide (2 arms). Primary endpoints: Oxygen saturation, Pulse rate and 2 more. Started Jun 2023; status: completed.

02

Drugs

ketaminemidazolamnitrous oxide

Beyond the preview

Go deeper on IRCT20160307026950N51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160307026950N51.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call